Valeritas CEO John Timberlake to Participate as a Panelist on “Exploring Innovation in Diabetes Tech,” at DeviceTalks West Conference
28. November 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Study Supports Valeritas’ V-Go® Can Improve Glycemic Control in Type 2 Patients When Using an Easy to Follow Physician-Driven Insulin Titration Algorithm
26. November 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Announces Pricing of $36 Million Public Offering
15. November 2018 20:13 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Signs Exclusive Middle East Distribution Agreement with Julphar
13. November 2018 07:00 ET
|
Valeritas, Inc.
- V-Go distribution deals now span 14 countries and territories - BRIDGEWATER, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company, has...
Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical and Economic Benefits Across Established BMI Strata in Patients with Type 2 Diabetes Including Those Overweight and Obese
12. November 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple,...
Valeritas Reports Record Revenue for the Third Quarter 2018
09. November 2018 07:00 ET
|
Valeritas, Inc.
- Company’s Third Consecutive Quarter with Greater than 30% Year-Over-Year Revenue Growth - BRIDGEWATER, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...
Valeritas to Report Third Quarter 2018 Results November 9, 2018
05. November 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Announces That V-Go® Insulin Delivery Device Has Launched in Italy
19. Oktober 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Wins Fifth Consecutive Cardinal Health Supply Chain Excellence Award
17. Oktober 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Expects to Report Record Revenue for Third Quarter 2018
15. Oktober 2018 07:00 ET
|
Valeritas, Inc.
Third consecutive quarter with greater than 30% year-over-year revenue growth BRIDGEWATER, N.J., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology...